EMEA-000637-PIP01-09-M01

Key facts

Invented name
Fosrenol and associated name Foznol
Active substance
Lanthanum carbonate hydrate
Therapeutic area
Uro-nephrology
Decision number
P/22/2010
PIP number
EMEA-000637-PIP01-09-M01
Pharmaceutical form(s)
  • Chewable tablet
  • Granules
Condition(s) / indication(s)
Hyperphosphataemia
Route(s) of administration
Oral use
Contact for public enquiries
Shire Pharmaceutical Contracts Ltd
United Kingdom
Tel. +44 (0)1423 850717
E-mail: medinfoemea@shire.com 
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

How useful was this page?

Add your rating